Latest News:28/June/2013:MESH Sceintefic program started today..»28/June/2013:بدء نشاط مدرسة الشرق الأوسط لأمراض الكبد..»13/May/2013:adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma..»13/May/2013:Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening..»13/May/2013:FDA Limits Duration, Usage of Tolvaptan Due to Possible Liver Injury..»13/May/2013:Nephrology Online Course (NOC) on CKD..»4/May/2013:FDA OKs Kcentra for Fast Fix of Coumadin Bleeds..»22/April/2013:فى ذمه الله..وفاه حرم أ.د. عمرو حلمى..»17/April/2013:سيد الرئيس " محمد مرسي  يكرم أ/د جمال الدين عصمت في عيد العلم بمناسبة حصول سيادته على جائزة الدولة التقديرية في العلوم الطبية لعام..»27/December/2011:إختيار الأستاذ الدكتور/ جمال عصمت نائبا لرئيس جامعة القاهرة للدراسات العليا..»16/November/2011:Dr.Zayady had passed away..»16/November/2011:البقاء لله :توفى اليوم الى رحمة الله د. عبد الرحمن الزيادى أستاذ الكبد والجهازهضمى..»13/October/2011:دعوة للإنضمام إلى الطريق الأخر...القوة الثالثة..»26/August/2011:توفى الى رحمة الله تعالى بألمانيا المغفور له بإذن الله - الاستاذ الدكتور/ مصطفى كمال..»29/May/2011:New Treatments for Hepatitis C..»23/March/2010:Nitazoxanide is now available in Egypt..»23/March/2010:When and how to evaluate mildly elevated liver enzymes in apparently healthy patients..»28/February/2010:نقابة الأطباء تفتح باب التبرعات لتقديم الزكاة لأعضائها..»15/January/2010:New Project By NMMA supported by Coca Cola International..»

Member's Login

Skip Navigation Links.

Egyptian Liver Journal>>April issue

Books Library:

Migrating Birds:

Suggestion Home

Latest News

?Here you can read about the latest news from the network that we found usful for every client intersted in our site's topics,here u will find a variety of news that we hope it afficts your life positively..!!

adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma- 5/13/2013 12:00:00 AM

A systematic review and meta-analysis of adjuvant interferon therapy after curative treatment for patients with viral hepatitis-related hepatocellular carcinoma Journal of Viral Hepatitis, 04/17/2013  Evidence Based Medicine  Review Article  Clinical Article Huang TS et al. – The efficacy of adjuvant interferon treatment for the management of patients with viral hepatitis–related hepatocellular carcinoma (HCC) following curative treatment is controversial. There was little evidence for beneficial effects on patients with hepatitis B virus–related HCC. Future research should be aimed at clarifying whether the effects of adjuvant interferon therapy are more prominent in hepatitis C patients with sustained virological responses. Methods The authors have conducted a systematic review with meta–analysis to assess the effects of adjuvant interferon therapy on survival outcomes. Randomized and nonrandomized studies (NRSs) comparing adjuvant interferon treatment with the standard of care for viral hepatitis–related HCC after curative treatment were included. CENTRAL, Medline, EMBASE and the Science Citation Index were searched with complementary manual searches. The primary outcomes were recurrence–free survival (RFS) and overall survival (OS). Nine randomized trials and 13 NRSs were included in the meta–analysis. These nine randomized trials included 942 participants, of whom, 490 were randomized to the adjuvant interferon treatment group and 452 to the control group. Results The results of meta–analysis showed unexplained heterogeneity for both RFS and OS. The 13 NRSs included 2214 participants, of whom, 493 were assigned to the adjuvant interferon treatment group and 1721 to the control group. The results of meta–analysis showed that, compared with controls, adjuvant interferon treatment significantly improved the RFS [hazard ratio (HR) 0.66, 95% confidence interval (CI) 0.52–0.84, I2 = 29%] and OS (HR 0.43, 95% CI 0.34–0.56, I2 = 0%) of patients with hepatitis C virus–related HCC following curative treatment.

Search News

Date From:

Upcoming Events

International Events:

National Events: